Acetazolamide
Acetazolamide
Carbonic Anhydrase Inhibitor
NADAC/unit
$0.1003
No Shortage
Tier 1: 70.5%
26 Manufacturers
39 ANDAs
vs. brand Acetazolamide: Generic saves up to 99% per unit
Market Intelligence
2024-09-25 Class III Recall: Rubicon Research Private Limited
Generic Manufacturers
ACCORD HEALTHCARE INCALEMBIC PHARMACEUTICALS LTDAUROBINDO PHARMA LTDAVET LIFESCIENCES LTDCADILA HEALTHCARE LTDCHARTWELL MOLECULAR HOLDINGS LLCEPIC PHARMA LLCGLAND PHARMA LTDHERITAGE PHARMA LABS INCHIBROW HEALTHCARE PRIVATE LTDHIKMA PHARMACEUTICALS USA INCINDICUS PHARMA LLCMANKIND PHARMA LTDMICRO LABS LTD INDIAMPP PHARMA LLCMYLAN ASI LLCNE RX PHARMA LLCNOVAST LABORATORIES LTDNOVITIUM PHARMA LLCRUBICON RESEARCH LTDSOMERSET THERAPEUTICS LLCSTRIDES PHARMA GLOBAL PTE LTDTARO PHARMACEUTICAL INDUSTRIES LTDXGEN PHARMACEUTICALS DJB INCZYDUS LIFESCIENCES GLOBAL FZEZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.